MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Relationship between automatic analysis of gait disorder and eye movement capture by AI and cognitive function in Parkinson’s disease

    J. Cheng, JZ. Hu, XY. Cheng, CJ. Mao (Suzhou, China)

    Objective: Gait disorder is a hallmark of Parkinson’s disease (PD), with mounting evidence linking gait to cognitive function in PD patients and eye movements serving…
  • 2026 International Congress

    Peripheral Inflammatory Markers and Clinical Correlations in Parkinson’s Disease Patients Carrying LRRK2 G2385R and R1628P Variants

    HX. Ding, TS. Toh, NJ. Zulkefli, NS. Zulhaimi, AN. Khairul Anuar, JW. Hor, YW. Tay, IX. Kong, YC. Pang, R. Rajasuriar, SY. Lim, AH. Tan, LC. Lit (Kuala Lumpur, Malaysia)

    Objective: To investigate plasma cytokines and chemokines with clinical correlations between Parkinson’s disease (PD) patients carrying LRRK2 p.G2385R and/or p.R1628P variants, idiopathic PD (iPD), and healthy controls.…
  • 2026 International Congress

    MDSGene literature update on autosomal recessive Parkinson’s Disease

    T. Kleinz, M. Thomsen, S. Schaake, H. Madoev, M. Doquenia, L. Lange, J. Junker, K. Lohmann, C. Klein (Lübeck, Germany)

    Objective: To comprehensively characterize demographic, genetic, and phenotypic features in individuals with autosomal recessive Parkinson’s disease (PD), leveraging individual-level data from published literature. Background: In…
  • 2026 International Congress

    Safety and Effectiveness of DaxibotulinumtoxinA in Cervical Dystonia: A Systematic Review and Meta-Analysis of Different Doses

    H. Sabet, M. Aziz, M. Zanaty (Qena, Egypt)

    Objective: To evaluate the effectiveness and safety of DaxibotulinumtoxinA (DAXI) in patients diagnosed with cervical dystonia (CD). Background: Botulinum toxins (BoNTs) are the first-line therapy…
  • 2026 International Congress

    Comparison of Regional Perfusion Patterns in Clinical Subtypes of PSP and CBD: Dual Phase [¹⁸F]FP CIT PET Study

    C. Lee, S. Kim, J. Ko, D. Doudet (Seongnam, Republic of Korea)

    Objective: To investigate the regional perfusion patterns using PET imaging across various clinical subtypes of PSP and CBD. Background: On MRI, PSP typically shows midbrain…
  • 2026 International Congress

    Restoring the Axis: Efficacy of Fecal Microbiota Transplantation (FMT) on Motor and Non-Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2023–2025)

    Z. Hussein, A. Al-Zaidi, F. Al-Zaidi (Salahddin, Iraq)

    Objective: To methodically assess the safety and effectiveness of fecal microbiota transplantation (FMT) in comparison to a placebo for Parkinson's disease (PD) patients' motor and…
  • 2026 International Congress

    A case series of Spinocerebellar ataxia subtype 15 from Chile

    M. Niedbalski, M. Canals, F. Urbina, M. Leon, S. de Almorzara, M. Sánchez, M. Miranda (Santiago, Chile)

    Objective: To describe a series of patients in Santiago Chile with genetically confirmed SCA15. Background: Spinocerebellar ataxia (SCA) are genetic neurodegenerative diseases for which SCA…
  • 2026 International Congress

    Non-Motor Symptom Burden as a Key Determinant of Disease Clustering in Parkinson’s Disease

    A. Rekik, R. Guizani, L. Bouafia, A. Mili, K. Jemai, H. Slimene, A. Hassine, S. Naija, S. Ben Amor (Sousse, Tunisia)

    Objective: To evaluate how non-motor symptoms drive the classification of Parkinson’s disease (PD) patients beyond standard motor subtyping. Background: While motor symptoms are the hallmark…
  • 2026 International Congress

    Role and significance of C-reactive protein in stages of Parkinson’s disease

    R. Matmurodov, S. Jumanazarova, H. Daminova, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To сomparative analysis of the amount of CRP in the blood serum of patients according to the stages of PD. Background: C-reactive protein (CRP)…
  • 2026 International Congress

    The Transcriptomic, Neurotransmitter, and Cell Type Signatures Underlying Pure Fatigue in Early-stage Parkinson’s Disease

    Y. Xiao, S. Wang, Y. Hou, R. Ou, C. Li, W. Song, X. Shi, X. Zhu, H. Shang (Chengdu, China)

    Objective: This study elucidates spatiotemporal functional connectivity of pure fatigue in early Parkinson’s disease (PD) and uncovering underlying gene expression profiles. Background: Fatigue is a…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley